Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 25(2): 461-464, 2024 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-38415531

RESUMO

OBJECTIVE: A major part of the cytokines secreted from the immune system are interleukins (IL) and their main role is to stimulate the immune system cells. Therefore the genotypic effects of IL-6 and IL-10 on the immune system in CLL were investigated in the study. METHOD: For this purpose 100 patients diagnosed with CLL and 70 healthy individuals with no cancer history were included in the study. Polymorphisms at IL10 and IL 6 promoter regions (1082 A\G and 819 C\T) and IL6 (174 G\C) polymorphisms were analyzed with RT-PCR. Genotype and allele frequencies were directly calculated. RESULT: In 100 CLL patients, 45 wild type AA, 40 AG and 15 mutant type GG genotypes were found for the IL 10 1082 A\G region. Genotypic distribution of IL10 819 C\T region was determined as CC, BT and TT genotypes in 37, 50 and 13 patients, respectively. In IL 6 174 G\C region, GG, GC and CC genotypes were determined in 62, 30 and 8 patients, respectively. There is no statistically significant difference between the CLL patients and control groups in terms of IL10 1082 A\G, 819 C\T and IL 6 174 G/C regions (p> 0.05). As a result of the allele frequency calculation of the IL 10 1082 region, the values obtained were A (0.65), G (0.35) for the patient group and (0.61) and G (0.31) for the control group. 819 region allele frequencies were C (0.57) and T (0.33) in the patient group and C (0.48) and T (0.32) in the control group. The IL6 174 region was calculated as G (0.82), C (0.28) in the patient group and G (0.63), C (0.23) in the control group. Given the number of patients within the limits of this study, IL 10 and IL 6 genotype frequencies do not seem to be statistically related to CLL patients. CONCLUSION: Mutant alleles of all interleukin SNPs were determined at a higher frequency in the patient group as compared to the control group. Therefore, a potential correlation between the SNPs of these interleukins and CLL can be determined in future studies with a higher number of samples.


Assuntos
Interleucina-6 , Leucemia Linfocítica Crônica de Células B , Humanos , Alelos , Estudos de Casos e Controles , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Interleucina-10/genética , Interleucina-6/genética , Interleucinas/genética , Leucemia Linfocítica Crônica de Células B/genética , Polimorfismo de Nucleotídeo Único
2.
Hemoglobin ; 31(3): 387-91, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17654078

RESUMO

Hb D-Los Angeles (also known as D-Punjab, D-North Carolina, D-Portugal, D-Chicago and Oak Ridge) is an abnormal hemoglobin (Hb) with an amino acid substitution of glutamine for glutamic acid at codon 121 of the beta-globin gene. The origin and spread of Hb D-Los Angeles is not known. This is due to lack of information and remains to be elucidated. According to published reports, the Hb D-Los Angeles mutation is mostly linked with Mediterranean haplotype I [+ - - - - + +]. Besides the Mediterranean haplotype, a novel haplotype was also reported from Thailand [- - + + - - + + +]. Here we report a new haplotype from Turkey [- + -- + + +] that has not been described before. These results suggest that the Hb D-Los Angeles mutation has at least three different genetic origins.


Assuntos
Globinas/genética , Haplótipos , Hemoglobinas Anormais/genética , Humanos , Família Multigênica , Dinâmica Populacional , Turquia/etnologia
3.
Hemoglobin ; 30(3): 385-91, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16840230

RESUMO

The surface plasmon resonance (SPR) approach, being a relatively novel biophysical method, is used to detect many different targets by biomolecular interaction. The SPR system uses optical and evanescent wave phenomenon. This approach does not need any labels, such as enzymes or isotopes, and the monitored interactions are in real time. In DNA-DNA interaction, the SPR approach is Tm-independent. Here we report our preliminary results for the molecular detection of the Hb S (GAG -->GTG) mutation at codon 6 of the human beta-globin gene. Our preliminary results show that the SPR approach could be applied as an inexpensive and fast routine test system for the molecular diagnosis of abnormal hemoglobins (Hbs), especially in premarital screening programs.


Assuntos
Globinas/genética , Hemoglobina Falciforme/genética , Mutação Puntual/genética , Ressonância de Plasmônio de Superfície/métodos , Aconselhamento Genético , Humanos , Exames Pré-Nupciais/métodos
4.
Hemoglobin ; 29(4): 307-10, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16370495

RESUMO

Denizli Province is located in the inner part of the Aegean region of Turkey and is one of the target areas for premarital screening. Here we report the abnormal hemoglobins (Hbs) observed during a premarital screening program in our region. According to our results, Hb D-Los Angeles [beta1211(GH4)Glu-->Gln (GAA-->CAA] (also known as D-Punjab, D-North Carolina, D-Portugal, Oak Ridge and D-Chicago), is the most frequent abnormal Hb in this region.


Assuntos
Hemoglobinas Anormais/análise , Epidemiologia Molecular , Frequência do Gene , Testes Genéticos , Humanos , Incidência , Exames Pré-Nupciais , Turquia/epidemiologia
5.
Turk J Haematol ; 22(1): 19-23, 2005 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-27264513

RESUMO

Beta-thalassemia is one of the most common genetic disorders in Turkey as well as in several other Mediterranean countries presenting microcytosis and hemolytic anemia. The city of Denizli is located in the inner part of the Aegean geographical region of Turkey. The beta-thalassemia incidence in Denizli province is in between 2.6-3.7% reported by different researchers. According to our results; the IVS-1/nt-110 (G>A) is the most frequent mutation type in our province the same as other geographical regions of Turkey. Here we report also two HbD-Los Angeles/beta-thalassemia combinations, which are HbD-Los Angeles/codon 39 (C>T) and HbD-Los Angeles/IVS-1/nt-1 (G>A), respectively. In conclusion, our preliminary results show the heterogeneity of the beta-thalassemia mutations in the province of Denizli.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...